Diversity in Clinical Trials

We can work with you to encourage greater patient diversity and remove barriers to participation

Protocol Design

Patient Advocacy Group (PAG) Engagement

Working with community focus groups and PAGs to gather and share insights into protocol design elements and the recruitment tactics/tools used on the program.

This includes:

  • Scoping PAGs with existing patient networks to lead focus groups
  • Developing a recommendations report for study teams
  • Creating a sponsor response to the recommendations report for dissemination to the PAG
  • Relaying findings, outcomes and actions to future sites

Learn how we improve patient diversity in your clinical trials

Contact Us

Communications & Training Solutions

Training – Impact Through Upskilling

Providing study sites with advanced recruitment and engagement skills through specific education and interactive training programs. We do this through webinars, videos, remote coaching, investigator meetings and on-site training.

Communications – DICT Toolkit

Using culturally appropriate patient recruitment materials to increase awareness, education and access to clinical trials for all BAME populations.

We can design a bespoke, branded template toolkit for each CRO or Sponsor to use however they need, ensuring that materials are produced appropriately for specific BAME communities.

Let us show you how we have improved diversity for our clients

Let’s Talk

Site Resources

Community Outreach in Action

Working locally within communities and with community physicians to increase clinical trial awareness and engagement among those from BAME groups.

Our grassroots ‘boots on the ground’ approach means we are able to build relationships and trust with key community stakeholders. For example, we have visited churches, grocery stores, hair salons and gyms in order to reach specific populations and talk to them about clinical research. It’s an approach we are currently implementing with  The Christie NHS Foundation Trust, one of the worlds leading specialist hospitals in the UK, to make cancer clinical trials more accessible.

Are you looking to make your clinical studies more inclusive?

Get in touch

Diverse Patient Voice

Stakeholder Insights – DICT Survey

Elevating the voice of the community, to include previous clinical trial participants, sites and patients now so that we can improve the participant experience in the future. Our insight surveys consider:

  • Patient insights and research attitudes
  • Site insights and recruitment needs
  • Participant insights and experience

Click here for our Privacy Policy

Request our Diversity Outreach Case study

Download

Therapy Areas

We have extensive experience of study phases I to IV, adults and paediatrics and both acute and chronic conditions.

Let’s Talk
  • Intra Abdominal pain
  • Post Operative pain
  • Non Alcoholic Fatty Liver Disease (NAFLD)
  • Non Alcoholic Steatohepatitis (NASH)
  • Hypercholesterolaemia
  • Type II Diabetes
  • Anaemia
  • Haemophilia
  • Sickle Cell
  • Thrombocytopenia
  • Osteoarthritis
  • Atopic Dermatitis
  • Hidradenitis Suppurativa
  • Psoriasis
  • Crohn’s Disease
  • Ulcerative Colitis
  • Bacterial infection – Sepsis
  • C-Diff
  • Intra-abdominal Infectious Disease
  • Pneumonia
  • Ankylosing Spondylitis
  • Alopecia
  • Asthma
  • Atopic Dermatitis
  • Crohn’s Disease
  • Hidradenitis Suppurativa
  • Lupus
  • Nasal Polyps
  • Psoriasis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Ulcerative Colitis
  • Vitiligo
  • Alzheimer’s Disease
  • Epilepsy
  • Depression
  • Duchenne Muscular Dystrophy (DMD)
  • Dyskinesia in Cerebral Palsy
  • Migraine
  • Multiple Sclerosis
  • Parkinson’s Disease
  • Schizophrenia
  • Acute Myeloid Leukaemia
  • Basal Cell Carcinoma
  • Bladder Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Head & Neck Cancer
  • Liver Cancer
  • Lung Cancer
  • Lymphoma
  • Metastatic Bone Pain
  • Myelofibrosis
  • Mutant Tumours
  • NSCLC
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Solid Tumour
  • Treatment Resistance Post Cancer Treatment
  • Urothelial Cancer
  • Asthma
  • COPD
  • Over-active Bladder
  • Pneumonia
  • Urinary Tract Infection
  • Birth Control
  • Interstitial Cystitis
  • STD Prevention
  • Urinary Tract Infection